Oregon Family Advocated for MLD Newborn Screening
Parents of a toddler diagnosed with MLD are seeking state-mandated screening to ensure earlier detection of the condition.
Updated on Sept. 25, 2026 in Special Needs
Following their daughter Corina’s diagnosis of metachromatic leukodystrophy in November 2025, the Floch family has begun advocating for newborn screening mandates in Oregon. Federal authorities approved the screening in December 2025, a change that could improve early intervention for other infants.
Why it matters
Early detection of MLD is critical because existing treatments are significantly more effective before symptoms emerge. By pushing for state-level screening requirements, families aim to prevent the diagnostic delays that often impact outcomes for children with this rare condition.
Active MLD occurs in 1 in 40,000 births, and federal approval for newborn screening was granted in December 2025. While the condition is rare, the genetic risk is higher, with 1 in 100 people carrying the recessive gene for the disease.
The players
Corina Floch
A toddler diagnosed with MLD who uses a speech-generating device and a gastrostomy tube.
Oregon Health & Science University
A research university and healthcare provider in Portland that coordinates complex specialty care.
Children's Hospital of Philadelphia
A specialized pediatric facility that provides advanced care techniques for children with rare metabolic conditions.
The details
MLD is a metabolic condition that progresses until treatments are administered, ideally before clinical signs appear. Managing the condition often requires specialized care, such as nutrition delivered through a surgically implanted gastrostomy tube. Children like Corina frequently rely on adaptive tools, including speech-generating devices, to navigate their daily communication needs.
Timeline
May 19, 2023: Corina Floch was born.
November 2025: Corina received a diagnosis of MLD.
December 2025: The federal government approved newborn screening for MLD.
January 2026: The Floch family traveled to the Children's Hospital of Philadelphia for specialized care.
December 2026: Corina is scheduled for a Make-A-Wish trip to Disney World.
Health Landscape
The push for MLD screening follows the December 2025 federal approval of the test, marking a shift toward incorporating rare metabolic disorders into standard newborn screenings. This trajectory mirrors the historical adoption of other life-saving genetic panels now standard in pediatric care.
Families with concerns about genetic conditions or rare metabolic disorders should speak with a primary care physician or genetic counselor about current screening options. Understanding the importance of early detection can help parents prepare for necessary specialist consultations at centers like Oregon Health & Science University.
The takeaway
Early diagnosis is the most vital factor in improving outcomes for children with MLD. Parents interested in regional testing availability should consult their pediatrician to track state-level updates on newborn screening requirements.
Further reading
For resources on navigating pediatric care and support, visit Special Needs.
Source note: This article includes information reported by NewsRegister.
